680 W NYE LANE, CARSON CITY, NV
Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Stockholders Approve Amendment to 2019 Omnibus Equity Incentive Plan
Stockholders Elect Directors at BioVie Inc. Annual Meeting
Announces Closing of $12 Million Public Offering
Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
Material Modifications to Rights of Security Holders
Shareholder votes
Changes in Board, Management or Compensation
FY 2025
Q3
Q2
Q1
FY 2024
Amended Registration Statement for Securities
S-1
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Preliminary Information Statement
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Free Writing Prospectus
Post-Effective Amendment to Registration Statement
Correspondence